<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>147(1)</volume><submitter>Nientiedt M</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To investigate the mRNA expression of B-MYB and MDM2 together with their p53 relatedness in clear cell renal cell carcinoma (ccRCC).&lt;h4>Methods&lt;/h4>Genes were screened for their mRNA expression from 529 patients in a publicly available ccRCC cohort (TCGA). A cohort of 101 patients with ccRCC served as validation by qRT-PCR mRNA tissue expression analysis.&lt;h4>Results&lt;/h4>Expression: B-MYB expression was significantly higher in high-grade tumours (p &lt; 0.0001 and p = 0.048) and in advanced stages (p = 0.005 and p = 0.037) in both cohorts. Correlation: p53-B-MYB as well as MDM2-B-MYB showed significant correlations in local and low-grade ccRCCs, but not in high grade tumours or advanced stages (r &lt; 0.3 and/or p > 0.05). Survival: Multivariable Cox regression of the TCGA cohort </pubmed_abstract><journal>Journal of cancer research and clinical oncology</journal><pagination>129-138</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11802152</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>B-MYB-p53-related relevant regulator for the progression of clear cell renal cell carcinoma.</pubmed_title><pmcid>PMC11802152</pmcid><pubmed_authors>Muller K</pubmed_authors><pubmed_authors>Kriegmair MC</pubmed_authors><pubmed_authors>Waldbillig F</pubmed_authors><pubmed_authors>Nientiedt M</pubmed_authors><pubmed_authors>Erben P</pubmed_authors><pubmed_authors>Porubsky S</pubmed_authors><pubmed_authors>Nitschke K</pubmed_authors><pubmed_authors>Steidler A</pubmed_authors><pubmed_authors>Popovic ZV</pubmed_authors><pubmed_authors>Muhlbauer J</pubmed_authors></additional><is_claimable>false</is_claimable><name>B-MYB-p53-related relevant regulator for the progression of clear cell renal cell carcinoma.</name><description>&lt;h4>Purpose&lt;/h4>To investigate the mRNA expression of B-MYB and MDM2 together with their p53 relatedness in clear cell renal cell carcinoma (ccRCC).&lt;h4>Methods&lt;/h4>Genes were screened for their mRNA expression from 529 patients in a publicly available ccRCC cohort (TCGA). A cohort of 101 patients with ccRCC served as validation by qRT-PCR mRNA tissue expression analysis.&lt;h4>Results&lt;/h4>Expression: B-MYB expression was significantly higher in high-grade tumours (p &lt; 0.0001 and p = 0.048) and in advanced stages (p = 0.005 and p = 0.037) in both cohorts. Correlation: p53-B-MYB as well as MDM2-B-MYB showed significant correlations in local and low-grade ccRCCs, but not in high grade tumours or advanced stages (r &lt; 0.3 and/or p > 0.05). Survival: Multivariable Cox regression of the TCGA cohort </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2026-03-27T16:59:08.192Z</modification><creation>2025-08-28T03:09:03.579Z</creation></dates><accession>S-EPMC11802152</accession><cross_references><pubmed>32951068</pubmed><doi>10.1007/s00432-020-03392-7</doi></cross_references></HashMap>